ArticleImmunotherapy2022

Development of hepatitis triggered by SARS-CoV-2 vaccination in patient with cancer during immunotherapy: a case report.

Angioletta Lasagna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.